NORWICH – Norwich Pharmaceuticals is announcing organizational changes that will eliminate approximately one quarter of its workforce.

According to a statement released by Norwich Pharmaceuticals, changes are due to decreasing product demand and delayed production forecasts leading to an anticipated 25 percent workforce reduction.

The North Norwich-based manufacturer plans to direct its focus on products that are developed and acquired by its parent company, which it says will allow continuation of services to third-party partnerships.